Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| KLA Corporation(KLAC) | 15,848 | 21,883 | +6,035 | $14.20M | $23.60M | 17.82% | +$9.41M |
| Bristol-Myers Squibb Company(BMY) | 323,358 | 316,842 | -6,516 | $14.97M | $14.29M | 10.79% | -$678.6K |
| Corcept Therapeutics Incorporated(CORT) | 67,200 | 67,200 | 0 | $4.93M | $5.58M | 4.22% | +$652.5K |
| Prothena Corp PlcSHS SHS | 451,019 | 549,019 | +98,000 | $2.74M | $5.36M | 4.05% | +$2.62M |
| Stoke Therapeutics, Inc.(STOK) | 210,000 | 210,000 | 0 | $2.38M | $4.93M | 3.73% | +$2.55M |
| uniQure N.V.SHS(QURE) | 98,697 | 78,728 | -19,969 | $1.38M | $4.60M | 3.47% | +$3.22M |
| Ovintiv Inc.(OVV) | 107,500 | 107,500 | 0 | $4.09M | $4.34M | 3.28% | +$250.5K |
| Neurocrine Biosciences, Inc.(NBIX) | 30,940 | 28,690 | -2,250 | $3.89M | $4.03M | 3.04% | +$138.7K |
| Acadia Pharmaceuticals Inc | 187,800 | 171,000 | -16,800 | $4.05M | $3.65M | 2.76% | -$401.7K |
| Protagonist Therapeutics Inc | 48,000 | 48,000 | 0 | $2.65M | $3.19M | 2.41% | +$535.7K |
| Compass Therapeutics, Inc.(CMPX) | 0 | 872,938 | +872,938 | $0 | $3.06M | 2.31% | +$3.06M |
| Phreesia, Inc.(PHR) | 114,700 | 114,700 | 0 | $3.26M | $2.70M | 2.04% | -$566.6K |
| Castle Biosciences, Inc.(CSTL) | 110,600 | 110,600 | 0 | $2.26M | $2.52M | 1.90% | +$259.9K |
| Structure Therapeutics IncADR | 36,000 | 78,000 | +42,000 | $746.6K | $2.18M | 1.65% | +$1.44M |
| Biodesix, Inc.(BDSX) | 5,736,113 | 286,804 | -5,449,309 | $1.62M | $2.17M | 1.63% | +$546.6K |
| Quidelortho Corp | 72,548 | 72,548 | 0 | $2.09M | $2.14M | 1.61% | +$45.7K |
| Axogen, Inc.(AXGN) | 161,000 | 119,078 | -41,922 | $1.75M | $2.12M | 1.60% | +$377.5K |
| Amicus Therapeutics Inc COM | 28,000 | 253,000 | +225,000 | $160.4K | $1.99M | 1.51% | +$1.83M |
| Harrow, Inc.(HROW) | 60,000 | 40,000 | -20,000 | $1.83M | $1.93M | 1.46% | +$94.8K |
| EQT Corporation(EQT) | 34,619 | 34,619 | 0 | $2.02M | $1.88M | 1.42% | -$134.7K |
| Solid Biosciences Inc | 178,768 | 296,955 | +118,187 | $870.6K | $1.83M | 1.38% | +$961.6K |
| Olema Pharmaceuticals, Inc.(OLMA) | 134,000 | 174,000 | +40,000 | $570.8K | $1.70M | 1.29% | +$1.13M |
| Cytokinetics, Incorporated(CYTK) | 10,000 | 30,000 | +20,000 | $330.4K | $1.65M | 1.24% | +$1.32M |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $1.43M | $1.50M | 1.13% | +$69.5K |
| Foghorn Therapeutics Inc.(FHTX) | 310,930 | 281,730 | -29,200 | $1.46M | $1.38M | 1.04% | -$83.7K |
| NovoCure Limited(NVCR) | 101,000 | 102,100 | +1,100 | $1.80M | $1.32M | 1.00% | -$478.7K |
| United Therapeutics Corporation(UTHR) | 4,250 | 3,000 | -1,250 | $1.22M | $1.26M | 0.95% | +$36.4K |
| Immunome, Inc.(IMNM) | 60,000 | 105,000 | +45,000 | $558.0K | $1.23M | 0.93% | +$671.5K |
| Masimo Corp | 8,280 | 8,280 | 0 | $1.39M | $1.22M | 0.92% | -$171.1K |
| Bicycle Therapeutics PlcADS | 0 | 154,000 | +154,000 | $0 | $1.19M | 0.90% | +$1.19M |
| Treace Medical Concepts, Inc.(TMCI) | 176,947 | 176,947 | 0 | $1.04M | $1.19M | 0.90% | +$146.9K |
| Kiniksa Pharmaceuticals Ltd | 30,000 | 30,000 | 0 | $830.1K | $1.16M | 0.88% | +$334.8K |
| Outset Medical, Inc.(OM) | 34,584 | 78,584 | +44,000 | $664.4K | $1.11M | 0.84% | +$445.2K |
| Inhibrx Biosciences, Inc.(INBX) | 32,110 | 31,698 | -412 | $458.2K | $1.07M | 0.81% | +$609.4K |
| DocGo Inc.(DCGO) | 764,062 | 764,062 | 0 | $1.20M | $1.04M | 0.78% | -$160.5K |
| Intellia Therapeutics, Inc.(NTLA) | 60,000 | 60,000 | 0 | $562.8K | $1.04M | 0.78% | +$473.4K |
| Travere Therapeutics, Inc.(TVTX) | 103,000 | 43,060 | -59,940 | $1.52M | $1.03M | 0.78% | -$495.3K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 25,000 | 85,000 | +60,000 | $239.8K | $1.00M | 0.76% | +$760.7K |
| Scholar Rock Holding Corporation(SRRK) | 16,000 | 26,000 | +10,000 | $566.7K | $968.2K | 0.73% | +$401.5K |
| Xenon Pharmaceuticals Inc.(XENE) | 21,000 | 21,000 | 0 | $657.3K | $843.1K | 0.64% | +$185.8K |
| Kalvista Pharmaceuticals Inc | 67,000 | 67,000 | 0 | $757.4K | $816.1K | 0.62% | +$58.6K |
| Halozyme Therapeutics, Inc.(HALO) | 10,000 | 10,100 | +100 | $520.2K | $740.7K | 0.56% | +$220.5K |
| Axsome Therapeutics, Inc.(AXSM) | 6,000 | 6,000 | 0 | $626.3K | $728.7K | 0.55% | +$102.4K |
| Freeport-McMoRan Inc.CL B(FCX) | 18,033 | 18,044 | +11 | $781.7K | $707.7K | 0.53% | -$74.0K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 18,000 | 22,000 | +4,000 | $654.5K | $661.8K | 0.50% | +$7.3K |
| Pacific Biosciences of California, Inc.(PACB) | 400,000 | 500,000 | +100,000 | $496.0K | $640.0K | 0.48% | +$144.0K |
| Apogee Therapeutics Inc | 16,000 | 16,000 | 0 | $694.9K | $635.7K | 0.48% | -$59.2K |
| Elutia Inc.(ELUT) | 1,159,059 | 711,175 | -447,884 | $2.29M | $633.1K | 0.48% | -$1.66M |
| Voyager Therapeutics, Inc.(VYGR) | 0 | 134,918 | +134,918 | $0 | $630.1K | 0.48% | +$630.1K |
| Alphatec Holdings, Inc.(ATEC) | 33,000 | 33,000 | 0 | $366.3K | $479.8K | 0.36% | +$113.5K |
| BridgeBio Pharma, Inc.(BBIO) | 5,000 | 8,688 | +3,688 | $215.9K | $451.3K | 0.34% | +$235.4K |
| Avalo Therapeutics, Inc.(AVTX) | 0 | 31,000 | +31,000 | $0 | $394.0K | 0.30% | +$394.0K |
| Guardant Health, Inc.(GH) | 0 | 6,000 | +6,000 | $0 | $374.9K | 0.28% | +$374.9K |
| Pharvaris N V COM | 0 | 14,847 | +14,847 | $0 | $370.4K | 0.28% | +$370.4K |
| Zenas BioPharma, Inc.(ZBIO) | 16,500 | 16,500 | 0 | $159.9K | $366.3K | 0.28% | +$206.4K |
| Gossamer Bio, Inc.(GOSS) | 138,176 | 138,176 | 0 | $170.0K | $363.4K | 0.27% | +$193.4K |
| Apellis Pharmaceuticals Inc COM | 14,000 | 14,000 | 0 | $242.3K | $316.8K | 0.24% | +$74.5K |
| Ventyx Biosciences Inc | 28,800 | 98,827 | +70,027 | $61.6K | $307.4K | 0.23% | +$245.7K |
| Candel Therapeutics, Inc.(CADL) | 60,000 | 60,000 | 0 | $303.6K | $306.0K | 0.23% | +$2.4K |
| OrthoPediatrics Corp.(KIDS) | 26,000 | 16,000 | -10,000 | $558.5K | $296.5K | 0.22% | -$262.0K |
| TELA Bio, Inc.(TELA) | 155,000 | 155,000 | 0 | $300.7K | $230.9K | 0.17% | -$69.8K |
| Nektar Therapeutics(NKTR) | 0 | 4,021 | +4,021 | $0 | $228.8K | 0.17% | +$228.8K |
| Healthcare Select Sector Spdr FundSBI HEALTHCARE ST STR CARE ETF | 0 | 1,498 | +1,498 | $0 | $208.5K | 0.16% | +$208.5K |
| Karyopharm Therapeutics Inc.(KPTI) | 27,985 | 27,985 | 0 | $120.6K | $183.0K | 0.14% | +$62.4K |
| Applied Therapeutics Inc | 280,000 | 225,000 | -55,000 | $87.1K | $136.1K | 0.10% | +$49.0K |
| Cullinan Therapeutics, Inc.(CGEM) | 20,000 | 20,000 | 0 | $150.6K | $118.6K | 0.09% | -$32.0K |
| InflaRx N.V.(IFRX) | 50,000 | 50,000 | 0 | $39.5K | $67.0K | 0.05% | +$27.5K |
| Alumis Inc | 10,000 | 10,000 | 0 | $30.0K | $39.9K | 0.03% | +$9.9K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 17,000 | 17,000 | 0 | $19.7K | $25.7K | 0.02% | +$6.0K |
| 10x Genomics, Inc.CL A(TXG) | 22,000 | 0 | -22,000 | $254.8K | $0 | — | -$254.8K |
| Accelerate Diagnostics Inc | 325,239 | 0 | -325,239 | $2.1K | $0 | — | -$2.1K |
| Aptevo Therapeutics Inc | 10,000 | 0 | -10,000 | $30.5K | $0 | — | -$30.5K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 40,000 | 0 | -40,000 | $358.4K | $0 | — | -$358.4K |
| Blueprint Medicines Corp | 2,700 | 0 | -2,700 | $346.1K | $0 | — | -$346.1K |
| Cogent Biosciences, Inc.(COGT) | 40,000 | 0 | -40,000 | $287.2K | $0 | — | -$287.2K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 8,000 | 0 | -8,000 | $377.6K | $0 | — | -$377.6K |
| NeuroPace, Inc.(NPCE) | 16,442 | 0 | -16,442 | $183.2K | $0 | — | -$183.2K |
| Wave Life Sciences, Inc.SHS(WVE) | 40,300 | 0 | -40,300 | $261.9K | $0 | — | -$261.9K |
| Xencor, Inc.(XNCR) | 70,000 | 0 | -70,000 | $550.2K | $0 | — | -$550.2K |